Shopping Cart
- Remove All
Your shopping cart is currently empty
Anti-Apolipoprotein H/APOH Antibody (1Q693)
😃Good
Catalog No. TMAY-01771
Alias BG, B2GP1, B2G1, apolipoprotein H (β-2-glycoprotein I), apolipoprotein H (beta-2-glycoprotein I)
Anti-Apolipoprotein H/APOH Antibody (1Q693) is a Mouse antibody targeting Apolipoprotein H/APOH. Anti-Apolipoprotein H/APOH Antibody (1Q693) can be used in ELISA,FCM,ICC/IF.
Anti-Apolipoprotein H/APOH Antibody (1Q693)
Anti-Apolipoprotein H/APOH Antibody (1Q693)
😃Good
Catalog No. TMAY-01771Alias BG, B2GP1, B2G1, apolipoprotein H (β-2-glycoprotein I), apolipoprotein H (beta-2-glycoprotein I)
Anti-Apolipoprotein H/APOH Antibody (1Q693) is a Mouse antibody targeting Apolipoprotein H/APOH. Anti-Apolipoprotein H/APOH Antibody (1Q693) can be used in ELISA,FCM,ICC/IF.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 20 μL | $69 | 7-10 days | |
| 100 μL | $199 | 7-10 days |
Bulk & Custom
Add to Cart
Questions
View MoreContact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
| Description | Antibody Type: Mouse Monoclonal Application: ELISA, FCM, ICC/IF Reactivity: Human |
| Alias | BG, B2GP1, B2G1, apolipoprotein H (β-2-glycoprotein I), apolipoprotein H (beta-2-glycoprotein I) |
| Ig Type | Mouse IgG1 |
| Clone | 1Q693 |
| Reactivity | Human |
| Verified Activity | 1. Immunofluorescence staining of Human APOH in HepG2 or Hela cells. Cells were fixed with 4% PFA, permeabilzed with 1% Triton X-100 in PBS, blocked with 10% serum, and incubated with mouse anti-Human APOH monoclonal antibody (1:60). Then cells were stained with the Alexa Fluor® 488-conjugated Goat Anti-mouse IgG secondary antibody (left panel, captured by laser confocal scanning microscope; right panel, captured by fluorescence microscope), countstained with DAPI (blue). Positive staining was localized to cytoplasm. 2. Flow cytometric analysis of Human APOH expression on MDA-MB-231 cells. The cells were treated according to manufacturer’s manual (BD Pharmingen™ Cat. No. 554714), stained with purified anti-Human APOH, then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells. |
| Application | ELISA,FCM,ICC/IF |
| Recommended Dose | ELISA: 1:1000-1:2000; ICC-IF: 1:20-1:100; FCM: 1:25-1:100 |
| Antibody Type | Monoclonal |
| Host Species | Mouse |
| Construction | This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human APOH (rh APOH; TMPY-01278; NP_000033.2; Met 1-Cys 345). The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography. |
| Purification | Protein A |
| Appearance | Liquid |
| Formulation | 0.2 μm filtered solution in PBS |
| Research Background | Apolipoprotein H (APOH), also known as Beta-2-glycoprotein 1, Activated protein C-binding protein, B2GPI, and B2G1, is a glycoprotein synthesized by liver cells and it is present in the blood associated with plasma lipoproteins. It is an essential cofactor for the binding of certain antiphospholipid antibodies (APA) to anionic phospholipid. APOH binds to various kinds of negatively charged substances such as heparin, phospholipids, and dextran sulfate. APOH may prevent activation of the intrinsic blood coagulation cascade by binding to phospholipids on the surface of damaged cells. APOH appears to completely inhibit serotonin release by the platelets and prevents subsequent waves of the ADP-induced aggregation. The activity of APOH appears to involve the binding of agglutenating, negatively charged compounds, and inhibits agglutenation by the contact activation of the intrinsic blood coagulation pathway. APOH causes a reduction of the prothrombinase binding sites on platelets and reduces the activation caused by collagen when thrombin is present at physiological serum concentrations of APOH suggesting a regulatory role of APOH in coagulation. APOH plasma concentrations are strongly associated to metabolic syndrome alterations and vascular disease in type 2 diabetic and could be considered as a clinical marker of cardiovascular risk. APOH is found on several classes of lipoproteins, and is involved in the activation of lipoprotein lipase in lipid metabolism. This single-chain glycoprotein also has been implicated in several physiologic pathways including coagulation and the production of hypertension, which are related to the pathogenesis of primary cerebral hemorrhage (PICH). |
| Conjucates | Unconjugated |
| Immunogen | Recombinant Protein: Human APOH protein (TMPY-01278) |
| Antigen Species | Human |
Stability & Storage
| Stability & Storage | Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free. |
| Transport | Shipping with blue ice. |
Sci Citations
Calculator
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . 
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Anti-Apolipoprotein H/APOH Antibody (1Q693) | purchase Anti-Apolipoprotein H/APOH Antibody (1Q693) | Anti-Apolipoprotein H/APOH Antibody (1Q693) cost | order Anti-Apolipoprotein H/APOH Antibody (1Q693)
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.